Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sinovac Biotech Ltd (NASDAQ:SVA)

8.04
Delayed Data
As of Jan 19
 0.00 / 0.00%
Today’s Change
4.60
Today|||52-Week Range
8.11
+2.03%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues11.0M1.4M28.7M31.4M
 
 
 
 
 
Cost of Goods Sold3.2M2.3M4.5M7.4M
 
 
 
 
 
Depreciation And Amortization1.4M1.4M1.2M966.0K
 
 
 
 
 
 
Operating ExpensesGross Income6.3M-2.4M23.0M23.0M
 
 
 
 
 
General Expenses8.5M11.4M17.0M19.2M
 
 
 
 
 
Research And Development2.1M2.8M4.2M3.6M
 
 
 
 
 
Total Operating Expenses13.1M15.1M22.7M27.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.2M-13.7M6.0M3.9M
 
 
 
 
 
Interest Expense On Debt383.0K401.0K352.0K593.0K
 
 
 
 
 
Other Expenses646.0K-47.0K-1.0K6.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.6M-14.0M5.8M9.4M
 
 
 
 
 
Income Taxes-52.0K-1.4M-1.5M-2.6M
 
 
 
 
 
Minority Interest-560.0K-3.0M-1.1M-2.4M
 
 
 
 
 
Discontinued Operations2.3M0.000.000.00
 
 
Net Income1.3M-9.6M3.2M4.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS56.9M56.9M57.0M57.0M
 
 
 
 
 
Shares To Calculate EPS Diluted57.0M56.9M57.0M57.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.02-$0.17$0.06$0.08
 
 
 
 
 
EPS Diluted$0.02-$0.17$0.06$0.08